Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Genekine logo — Pioneering advancements in macromolecular drugs through inno...

Genekine

Pioneering advancements in macromolecular drugs through innovative protein expression and genetic engineering technologies

Founded 2012 Undisclosed Biotechnology, Health Care

General Information

Company Name Genekine
Founded Year 2012
Industries Biotechnology, Health Care
Funding Stage Undisclosed
Social

Get notified when Genekine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genekine

Genekine is a pioneering biotechnology enterprise founded in 2012, specializing in the research and development of macromolecular drugs. Their slogan "Pioneering advancements in macromolecular drugs through innovative protein expression and genetic engineering technologies" underscores their commitment to innovation. Genekine's focus lies in the research and industrialization of new protein expression systems using genetic engineering, protein engineering, glycoengineering, and other related biotechnologies. The company secured its most recent round of investment on 27 August 2018, attracting funding from PH Capital and Zhejiang Business Chanrong Holding. With a primary focus on the biotechnology and healthcare industries, Genekine is well-positioned to leverage its advanced technologies and innovative approach to make significant contributions in the field of macromolecular drugs.

Taxonomy: macromolecular drugs, protein expression, genetic engineering, protein engineering, glycoengineering, industrialization

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round •••••• 2
Investor
•••• •••• 		27 Aug 2018

Genekine Alternatives & Competitors

Genekine vs
RevolKa Ltd.
RevolKa Ltd. Japan

Contribute to the health and well-being of people by using our innovative AI assisted protein engine...

11 employees
Genekine vs
ATG Biotechnology
ATG Biotechnology

Pioneering enzyme gene modification and advanced protein engineering to enhance life science researc...

Series A
Biopharma, Biotechnology
Genekine vs
EmendoBio
EmendoBio United States

Making any gene targetable

Corporate Round
41 employees
Biotechnology, Health Care

FAQ About Genekine

Pioneering advancements in macromolecular drugs through innovative protein expression and genetic engineering technologies
Genekine was founded in 2012.
Genekine operates in the following industries: Biotechnology, Health Care.
Genekine has completed 1 funding round. The latest funding stage is Undisclosed.
Top alternatives and competitors to Genekine include RevolKa Ltd., ATG Biotechnology, EmendoBio, A-Alpha Bio, Provolut. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genekine and RevolKa Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genekine and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy